BackCompass Pathways Plc Overview
Compass Pathways Plc - ADR

Compass Pathways Plc Target Price

Where could CMPS trade next? Consensus target price: $18.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.72

Average Target Price

$18.4434.4% upside

9 analysts in the last 4 months

High: $25 | Low: $13

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-27Wells FargoBenjamin Burnett$135.2% downsideOpen
2026-07-20B.Riley FinancialMadison El-Saadi$1723.9% upsideOpen
2026-07-07Stifel NicolausPaul Matteis$2153.1% upsideOpen
2026-07-07Compass Point$2582.2% upsideOpen
2026-05-15Maxim GroupJason McCarthy$2045.8% upsideOpen
2026-05-14Morgan StanleyJudah Frommer$1723.9% upsideOpen
2026-05-07UBS$1831.2% upsideOpen
2026-05-03Jefferies$1831.2% upsideOpen
2026-04-24UBS$1723.9% upsideOpen
2026-02-18RBC Capital$2260.3% upsideOpen
2026-02-18Morgan StanleyVikram Purohit$1831.2% upsideOpen
2026-02-18Canaccord GenuitySumant Kulkarni$2045.8% upsideOpen
2026-02-12Compass PointFrancois Brisebois$159.3% upsideOpen
2026-01-23RBC CapitalLeonid Timashev$2153.1% upsideOpen
2025-12-09Oppenheimer$159.3% upsideOpen
2024-07-22RBC CapitalLeonid Timashev$2367.6% upsideOpen
2024-06-05Morgan StanleyVikram Purohit$2367.6% upsideOpen

Compass Pathways Plc (CMPS) FAQ

Compass Pathways Plc's target price stands at $18. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $18 for CMPS implies 34.4% upside versus today's price ($13.72). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Compass Pathways Plc's target price evolved across reporting periods, while the comparison chart places CMPS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Compass Pathways Plc's reading of $18 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.